Medical Care
Global Breast Cancer Testing Market Insights, Forecast to 2030
- Mar 07, 25
- ID: 687
- Pages: 110
- Figures: 136
- Views: 1
Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women's life and health.In recent years, as people pay more attention to women's health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, diagnostic tests and monitoring tests.Screening tests, such as annual mammograms, are given regularly to people who appear healthy and who are not suspected of having breast cancer.The goal is to detect breast cancer early, before any symptoms appear, and cancer is often easier to treat.Diagnostic tests (such as biopsies) are for people suspected of having breast cancer (such as biopsies).These tests are used to determine whether breast cancer is present and, if so, whether it has reached the outside of the breast.Diagnostic tests are also used to gather more information about cancer to guide treatment decisions.Once breast cancer is diagnosed, many tests are used during and after treatment to monitor how well therapies are working. Monitoring tests also may be used to check for any signs of recurrence.
Market Analysis and Insights: Global Breast Cancer Testing Market
The global Breast Cancer Testing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Breast Cancer Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Breast Cancer Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Breast Cancer Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Breast Cancer Testing include Abbott, Alere, Becton Dickinson, BioMerieux, Roche, GE Healthcare, Hologic, Philips and PerkinElmer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Breast Cancer Testing is widely used in various fields, such as Non-invasive Breast Cancer and Invasive Breast Cancer, etc. Non-invasive Breast Cancer provides greatest supports to the Breast Cancer Testing industry development. In 2023, global % revenue of Breast Cancer Testing went into Non-invasive Breast Cancer filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Breast Cancer Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Breast Cancer Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Breast Cancer Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Breast Cancer Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Breast Cancer Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Breast Cancer Testing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Abbott
Alere
Becton Dickinson
BioMerieux
Roche
GE Healthcare
Hologic
Philips
PerkinElmer
Quest Diagnostics
Segment by Type
Screening Tests
Diagnostic Tests
Monitoring Tests
Segment by Application
Non-invasive Breast Cancer
Invasive Breast Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Breast Cancer Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Cancer Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Breast Cancer Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global Breast Cancer Testing Market
The global Breast Cancer Testing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Breast Cancer Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Breast Cancer Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Breast Cancer Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Breast Cancer Testing include Abbott, Alere, Becton Dickinson, BioMerieux, Roche, GE Healthcare, Hologic, Philips and PerkinElmer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Breast Cancer Testing is widely used in various fields, such as Non-invasive Breast Cancer and Invasive Breast Cancer, etc. Non-invasive Breast Cancer provides greatest supports to the Breast Cancer Testing industry development. In 2023, global % revenue of Breast Cancer Testing went into Non-invasive Breast Cancer filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Breast Cancer Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Breast Cancer Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Breast Cancer Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Breast Cancer Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Breast Cancer Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Breast Cancer Testing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Abbott
Alere
Becton Dickinson
BioMerieux
Roche
GE Healthcare
Hologic
Philips
PerkinElmer
Quest Diagnostics
Segment by Type
Screening Tests
Diagnostic Tests
Monitoring Tests
Segment by Application
Non-invasive Breast Cancer
Invasive Breast Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Breast Cancer Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Cancer Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Breast Cancer Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Cancer Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Screening Tests
1.2.3 Diagnostic Tests
1.2.4 Monitoring Tests
1.3 Market by Application
1.3.1 Global Breast Cancer Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Non-invasive Breast Cancer
1.3.3 Invasive Breast Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Breast Cancer Testing Market Perspective (2019-2030)
2.2 Global Breast Cancer Testing Growth Trends by Region
2.2.1 Breast Cancer Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Breast Cancer Testing Historic Market Size by Region (2019-2024)
2.2.3 Breast Cancer Testing Forecasted Market Size by Region (2025-2030)
2.3 Breast Cancer Testing Market Dynamics
2.3.1 Breast Cancer Testing Industry Trends
2.3.2 Breast Cancer Testing Market Drivers
2.3.3 Breast Cancer Testing Market Challenges
2.3.4 Breast Cancer Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Breast Cancer Testing by Players
3.1.1 Global Breast Cancer Testing Revenue by Players (2019-2024)
3.1.2 Global Breast Cancer Testing Revenue Market Share by Players (2019-2024)
3.2 Global Breast Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Breast Cancer Testing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Breast Cancer Testing Market Concentration Ratio
3.4.1 Global Breast Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Testing Revenue in 2023
3.5 Global Key Players of Breast Cancer Testing Head office and Area Served
3.6 Global Key Players of Breast Cancer Testing, Product and Application
3.7 Global Key Players of Breast Cancer Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Cancer Testing Breakdown Data by Type
4.1 Global Breast Cancer Testing Historic Market Size by Type (2019-2024)
4.2 Global Breast Cancer Testing Forecasted Market Size by Type (2025-2030)
5 Breast Cancer Testing Breakdown Data by Application
5.1 Global Breast Cancer Testing Historic Market Size by Application (2019-2024)
5.2 Global Breast Cancer Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Breast Cancer Testing Market Size (2019-2030)
6.2 North America Breast Cancer Testing Market Size by Type
6.2.1 North America Breast Cancer Testing Market Size by Type (2019-2024)
6.2.2 North America Breast Cancer Testing Market Size by Type (2025-2030)
6.2.3 North America Breast Cancer Testing Market Share by Type (2019-2030)
6.3 North America Breast Cancer Testing Market Size by Application
6.3.1 North America Breast Cancer Testing Market Size by Application (2019-2024)
6.3.2 North America Breast Cancer Testing Market Size by Application (2025-2030)
6.3.3 North America Breast Cancer Testing Market Share by Application (2019-2030)
6.4 North America Breast Cancer Testing Market Size by Country
6.4.1 North America Breast Cancer Testing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Breast Cancer Testing Market Size by Country (2019-2024)
6.4.3 North America Breast Cancer Testing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Breast Cancer Testing Market Size (2019-2030)
7.2 Europe Breast Cancer Testing Market Size by Type
7.2.1 Europe Breast Cancer Testing Market Size by Type (2019-2024)
7.2.2 Europe Breast Cancer Testing Market Size by Type (2025-2030)
7.2.3 Europe Breast Cancer Testing Market Share by Type (2019-2030)
7.3 Europe Breast Cancer Testing Market Size by Application
7.3.1 Europe Breast Cancer Testing Market Size by Application (2019-2024)
7.3.2 Europe Breast Cancer Testing Market Size by Application (2025-2030)
7.3.3 Europe Breast Cancer Testing Market Share by Application (2019-2030)
7.4 Europe Breast Cancer Testing Market Size by Country
7.4.1 Europe Breast Cancer Testing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Breast Cancer Testing Market Size by Country (2019-2024)
7.4.3 Europe Breast Cancer Testing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Breast Cancer Testing Market Size (2019-2030)
8.2 China Breast Cancer Testing Market Size by Type
8.2.1 China Breast Cancer Testing Market Size by Type (2019-2024)
8.2.2 China Breast Cancer Testing Market Size by Type (2025-2030)
8.2.3 China Breast Cancer Testing Market Share by Type (2019-2030)
8.3 China Breast Cancer Testing Market Size by Application
8.3.1 China Breast Cancer Testing Market Size by Application (2019-2024)
8.3.2 China Breast Cancer Testing Market Size by Application (2025-2030)
8.3.3 China Breast Cancer Testing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Breast Cancer Testing Market Size (2019-2030)
9.2 Asia Breast Cancer Testing Market Size by Type
9.2.1 Asia Breast Cancer Testing Market Size by Type (2019-2024)
9.2.2 Asia Breast Cancer Testing Market Size by Type (2025-2030)
9.2.3 Asia Breast Cancer Testing Market Share by Type (2019-2030)
9.3 Asia Breast Cancer Testing Market Size by Application
9.3.1 Asia Breast Cancer Testing Market Size by Application (2019-2024)
9.3.2 Asia Breast Cancer Testing Market Size by Application (2025-2030)
9.3.3 Asia Breast Cancer Testing Market Share by Application (2019-2030)
9.4 Asia Breast Cancer Testing Market Size by Region
9.4.1 Asia Breast Cancer Testing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Breast Cancer Testing Market Size by Region (2019-2024)
9.4.3 Asia Breast Cancer Testing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Breast Cancer Testing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Breast Cancer Testing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Breast Cancer Testing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Breast Cancer Testing Introduction
11.1.4 Abbott Revenue in Breast Cancer Testing Business (2019-2024)
11.1.5 Abbott Recent Developments
11.2 Alere
11.2.1 Alere Company Details
11.2.2 Alere Business Overview
11.2.3 Alere Breast Cancer Testing Introduction
11.2.4 Alere Revenue in Breast Cancer Testing Business (2019-2024)
11.2.5 Alere Recent Developments
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Details
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Breast Cancer Testing Introduction
11.3.4 Becton Dickinson Revenue in Breast Cancer Testing Business (2019-2024)
11.3.5 Becton Dickinson Recent Developments
11.4 BioMerieux
11.4.1 BioMerieux Company Details
11.4.2 BioMerieux Business Overview
11.4.3 BioMerieux Breast Cancer Testing Introduction
11.4.4 BioMerieux Revenue in Breast Cancer Testing Business (2019-2024)
11.4.5 BioMerieux Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Breast Cancer Testing Introduction
11.5.4 Roche Revenue in Breast Cancer Testing Business (2019-2024)
11.5.5 Roche Recent Developments
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Breast Cancer Testing Introduction
11.6.4 GE Healthcare Revenue in Breast Cancer Testing Business (2019-2024)
11.6.5 GE Healthcare Recent Developments
11.7 Hologic
11.7.1 Hologic Company Details
11.7.2 Hologic Business Overview
11.7.3 Hologic Breast Cancer Testing Introduction
11.7.4 Hologic Revenue in Breast Cancer Testing Business (2019-2024)
11.7.5 Hologic Recent Developments
11.8 Philips
11.8.1 Philips Company Details
11.8.2 Philips Business Overview
11.8.3 Philips Breast Cancer Testing Introduction
11.8.4 Philips Revenue in Breast Cancer Testing Business (2019-2024)
11.8.5 Philips Recent Developments
11.9 PerkinElmer
11.9.1 PerkinElmer Company Details
11.9.2 PerkinElmer Business Overview
11.9.3 PerkinElmer Breast Cancer Testing Introduction
11.9.4 PerkinElmer Revenue in Breast Cancer Testing Business (2019-2024)
11.9.5 PerkinElmer Recent Developments
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Details
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Breast Cancer Testing Introduction
11.10.4 Quest Diagnostics Revenue in Breast Cancer Testing Business (2019-2024)
11.10.5 Quest Diagnostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Cancer Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Screening Tests
1.2.3 Diagnostic Tests
1.2.4 Monitoring Tests
1.3 Market by Application
1.3.1 Global Breast Cancer Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Non-invasive Breast Cancer
1.3.3 Invasive Breast Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Breast Cancer Testing Market Perspective (2019-2030)
2.2 Global Breast Cancer Testing Growth Trends by Region
2.2.1 Breast Cancer Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Breast Cancer Testing Historic Market Size by Region (2019-2024)
2.2.3 Breast Cancer Testing Forecasted Market Size by Region (2025-2030)
2.3 Breast Cancer Testing Market Dynamics
2.3.1 Breast Cancer Testing Industry Trends
2.3.2 Breast Cancer Testing Market Drivers
2.3.3 Breast Cancer Testing Market Challenges
2.3.4 Breast Cancer Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Breast Cancer Testing by Players
3.1.1 Global Breast Cancer Testing Revenue by Players (2019-2024)
3.1.2 Global Breast Cancer Testing Revenue Market Share by Players (2019-2024)
3.2 Global Breast Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Breast Cancer Testing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Breast Cancer Testing Market Concentration Ratio
3.4.1 Global Breast Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Testing Revenue in 2023
3.5 Global Key Players of Breast Cancer Testing Head office and Area Served
3.6 Global Key Players of Breast Cancer Testing, Product and Application
3.7 Global Key Players of Breast Cancer Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Cancer Testing Breakdown Data by Type
4.1 Global Breast Cancer Testing Historic Market Size by Type (2019-2024)
4.2 Global Breast Cancer Testing Forecasted Market Size by Type (2025-2030)
5 Breast Cancer Testing Breakdown Data by Application
5.1 Global Breast Cancer Testing Historic Market Size by Application (2019-2024)
5.2 Global Breast Cancer Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Breast Cancer Testing Market Size (2019-2030)
6.2 North America Breast Cancer Testing Market Size by Type
6.2.1 North America Breast Cancer Testing Market Size by Type (2019-2024)
6.2.2 North America Breast Cancer Testing Market Size by Type (2025-2030)
6.2.3 North America Breast Cancer Testing Market Share by Type (2019-2030)
6.3 North America Breast Cancer Testing Market Size by Application
6.3.1 North America Breast Cancer Testing Market Size by Application (2019-2024)
6.3.2 North America Breast Cancer Testing Market Size by Application (2025-2030)
6.3.3 North America Breast Cancer Testing Market Share by Application (2019-2030)
6.4 North America Breast Cancer Testing Market Size by Country
6.4.1 North America Breast Cancer Testing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Breast Cancer Testing Market Size by Country (2019-2024)
6.4.3 North America Breast Cancer Testing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Breast Cancer Testing Market Size (2019-2030)
7.2 Europe Breast Cancer Testing Market Size by Type
7.2.1 Europe Breast Cancer Testing Market Size by Type (2019-2024)
7.2.2 Europe Breast Cancer Testing Market Size by Type (2025-2030)
7.2.3 Europe Breast Cancer Testing Market Share by Type (2019-2030)
7.3 Europe Breast Cancer Testing Market Size by Application
7.3.1 Europe Breast Cancer Testing Market Size by Application (2019-2024)
7.3.2 Europe Breast Cancer Testing Market Size by Application (2025-2030)
7.3.3 Europe Breast Cancer Testing Market Share by Application (2019-2030)
7.4 Europe Breast Cancer Testing Market Size by Country
7.4.1 Europe Breast Cancer Testing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Breast Cancer Testing Market Size by Country (2019-2024)
7.4.3 Europe Breast Cancer Testing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Breast Cancer Testing Market Size (2019-2030)
8.2 China Breast Cancer Testing Market Size by Type
8.2.1 China Breast Cancer Testing Market Size by Type (2019-2024)
8.2.2 China Breast Cancer Testing Market Size by Type (2025-2030)
8.2.3 China Breast Cancer Testing Market Share by Type (2019-2030)
8.3 China Breast Cancer Testing Market Size by Application
8.3.1 China Breast Cancer Testing Market Size by Application (2019-2024)
8.3.2 China Breast Cancer Testing Market Size by Application (2025-2030)
8.3.3 China Breast Cancer Testing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Breast Cancer Testing Market Size (2019-2030)
9.2 Asia Breast Cancer Testing Market Size by Type
9.2.1 Asia Breast Cancer Testing Market Size by Type (2019-2024)
9.2.2 Asia Breast Cancer Testing Market Size by Type (2025-2030)
9.2.3 Asia Breast Cancer Testing Market Share by Type (2019-2030)
9.3 Asia Breast Cancer Testing Market Size by Application
9.3.1 Asia Breast Cancer Testing Market Size by Application (2019-2024)
9.3.2 Asia Breast Cancer Testing Market Size by Application (2025-2030)
9.3.3 Asia Breast Cancer Testing Market Share by Application (2019-2030)
9.4 Asia Breast Cancer Testing Market Size by Region
9.4.1 Asia Breast Cancer Testing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Breast Cancer Testing Market Size by Region (2019-2024)
9.4.3 Asia Breast Cancer Testing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Breast Cancer Testing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Breast Cancer Testing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Breast Cancer Testing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Breast Cancer Testing Introduction
11.1.4 Abbott Revenue in Breast Cancer Testing Business (2019-2024)
11.1.5 Abbott Recent Developments
11.2 Alere
11.2.1 Alere Company Details
11.2.2 Alere Business Overview
11.2.3 Alere Breast Cancer Testing Introduction
11.2.4 Alere Revenue in Breast Cancer Testing Business (2019-2024)
11.2.5 Alere Recent Developments
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Details
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Breast Cancer Testing Introduction
11.3.4 Becton Dickinson Revenue in Breast Cancer Testing Business (2019-2024)
11.3.5 Becton Dickinson Recent Developments
11.4 BioMerieux
11.4.1 BioMerieux Company Details
11.4.2 BioMerieux Business Overview
11.4.3 BioMerieux Breast Cancer Testing Introduction
11.4.4 BioMerieux Revenue in Breast Cancer Testing Business (2019-2024)
11.4.5 BioMerieux Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Breast Cancer Testing Introduction
11.5.4 Roche Revenue in Breast Cancer Testing Business (2019-2024)
11.5.5 Roche Recent Developments
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Breast Cancer Testing Introduction
11.6.4 GE Healthcare Revenue in Breast Cancer Testing Business (2019-2024)
11.6.5 GE Healthcare Recent Developments
11.7 Hologic
11.7.1 Hologic Company Details
11.7.2 Hologic Business Overview
11.7.3 Hologic Breast Cancer Testing Introduction
11.7.4 Hologic Revenue in Breast Cancer Testing Business (2019-2024)
11.7.5 Hologic Recent Developments
11.8 Philips
11.8.1 Philips Company Details
11.8.2 Philips Business Overview
11.8.3 Philips Breast Cancer Testing Introduction
11.8.4 Philips Revenue in Breast Cancer Testing Business (2019-2024)
11.8.5 Philips Recent Developments
11.9 PerkinElmer
11.9.1 PerkinElmer Company Details
11.9.2 PerkinElmer Business Overview
11.9.3 PerkinElmer Breast Cancer Testing Introduction
11.9.4 PerkinElmer Revenue in Breast Cancer Testing Business (2019-2024)
11.9.5 PerkinElmer Recent Developments
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Details
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Breast Cancer Testing Introduction
11.10.4 Quest Diagnostics Revenue in Breast Cancer Testing Business (2019-2024)
11.10.5 Quest Diagnostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Breast Cancer Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Screening Tests
Table 3. Key Players of Diagnostic Tests
Table 4. Key Players of Monitoring Tests
Table 5. Global Breast Cancer Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Breast Cancer Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Breast Cancer Testing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Breast Cancer Testing Market Share by Region (2019-2024)
Table 9. Global Breast Cancer Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Breast Cancer Testing Market Share by Region (2025-2030)
Table 11. Breast Cancer Testing Market Trends
Table 12. Breast Cancer Testing Market Drivers
Table 13. Breast Cancer Testing Market Challenges
Table 14. Breast Cancer Testing Market Restraints
Table 15. Global Breast Cancer Testing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Breast Cancer Testing Revenue Share by Players (2019-2024)
Table 17. Global Top Breast Cancer Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Testing as of 2023)
Table 18. Global Breast Cancer Testing Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Breast Cancer Testing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Breast Cancer Testing, Headquarters and Area Served
Table 21. Global Key Players of Breast Cancer Testing, Product and Application
Table 22. Global Key Players of Breast Cancer Testing, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Breast Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Breast Cancer Testing Revenue Market Share by Type (2019-2024)
Table 26. Global Breast Cancer Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Breast Cancer Testing Revenue Market Share by Type (2025-2030)
Table 28. Global Breast Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Breast Cancer Testing Revenue Share by Application (2019-2024)
Table 30. Global Breast Cancer Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Breast Cancer Testing Revenue Share by Application (2025-2030)
Table 32. North America Breast Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Breast Cancer Testing Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Breast Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Breast Cancer Testing Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Breast Cancer Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Breast Cancer Testing Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Breast Cancer Testing Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Breast Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Breast Cancer Testing Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Breast Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Breast Cancer Testing Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Breast Cancer Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Breast Cancer Testing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Breast Cancer Testing Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Breast Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Breast Cancer Testing Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Breast Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Breast Cancer Testing Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Breast Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Breast Cancer Testing Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Breast Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Breast Cancer Testing Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Breast Cancer Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Breast Cancer Testing Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Breast Cancer Testing Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Breast Cancer Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Country (2025-2030) & (US$ Million)
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott Breast Cancer Testing Product
Table 67. Abbott Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 68. Abbott Recent Developments
Table 69. Alere Company Details
Table 70. Alere Business Overview
Table 71. Alere Breast Cancer Testing Product
Table 72. Alere Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 73. Alere Recent Developments
Table 74. Becton Dickinson Company Details
Table 75. Becton Dickinson Business Overview
Table 76. Becton Dickinson Breast Cancer Testing Product
Table 77. Becton Dickinson Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 78. Becton Dickinson Recent Developments
Table 79. BioMerieux Company Details
Table 80. BioMerieux Business Overview
Table 81. BioMerieux Breast Cancer Testing Product
Table 82. BioMerieux Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 83. BioMerieux Recent Developments
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Breast Cancer Testing Product
Table 87. Roche Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 88. Roche Recent Developments
Table 89. GE Healthcare Company Details
Table 90. GE Healthcare Business Overview
Table 91. GE Healthcare Breast Cancer Testing Product
Table 92. GE Healthcare Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 93. GE Healthcare Recent Developments
Table 94. Hologic Company Details
Table 95. Hologic Business Overview
Table 96. Hologic Breast Cancer Testing Product
Table 97. Hologic Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 98. Hologic Recent Developments
Table 99. Philips Company Details
Table 100. Philips Business Overview
Table 101. Philips Breast Cancer Testing Product
Table 102. Philips Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 103. Philips Recent Developments
Table 104. PerkinElmer Company Details
Table 105. PerkinElmer Business Overview
Table 106. PerkinElmer Breast Cancer Testing Product
Table 107. PerkinElmer Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 108. PerkinElmer Recent Developments
Table 109. Quest Diagnostics Company Details
Table 110. Quest Diagnostics Business Overview
Table 111. Quest Diagnostics Breast Cancer Testing Product
Table 112. Quest Diagnostics Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 113. Quest Diagnostics Recent Developments
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Breast Cancer Testing Market Share by Type: 2023 VS 2030
Figure 3. Screening Tests Features
Figure 4. Diagnostic Tests Features
Figure 5. Monitoring Tests Features
Figure 6. Global Breast Cancer Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Breast Cancer Testing Market Share by Application: 2023 VS 2030
Figure 8. Non-invasive Breast Cancer Case Studies
Figure 9. Invasive Breast Cancer Case Studies
Figure 10. Breast Cancer Testing Report Years Considered
Figure 11. Global Breast Cancer Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Breast Cancer Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Breast Cancer Testing Market Share by Region: 2023 VS 2030
Figure 14. Global Breast Cancer Testing Market Share by Players in 2023
Figure 15. Global Top Breast Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Testing as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Breast Cancer Testing Revenue in 2023
Figure 17. North America Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Breast Cancer Testing Market Share by Type (2019-2030)
Figure 19. North America Breast Cancer Testing Market Share by Application (2019-2030)
Figure 20. North America Breast Cancer Testing Market Share by Country (2019-2030)
Figure 21. United States Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Breast Cancer Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 24. Europe Breast Cancer Testing Market Share by Type (2019-2030)
Figure 25. Europe Breast Cancer Testing Market Share by Application (2019-2030)
Figure 26. Europe Breast Cancer Testing Market Share by Country (2019-2030)
Figure 27. Germany Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. China Breast Cancer Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 34. China Breast Cancer Testing Market Share by Type (2019-2030)
Figure 35. China Breast Cancer Testing Market Share by Application (2019-2030)
Figure 36. Asia Breast Cancer Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 37. Asia Breast Cancer Testing Market Share by Type (2019-2030)
Figure 38. Asia Breast Cancer Testing Market Share by Application (2019-2030)
Figure 39. Asia Breast Cancer Testing Market Share by Region (2019-2030)
Figure 40. Japan Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Taiwan Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Breast Cancer Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Breast Cancer Testing Market Share by Type (2019-2030)
Figure 48. Middle East, Africa, and Latin America Breast Cancer Testing Market Share by Application (2019-2030)
Figure 49. Middle East, Africa, and Latin America Breast Cancer Testing Market Share by Country (2019-2030)
Figure 50. Brazil Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Mexico Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Turkey Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Israel Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. GCC Countries Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Abbott Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 57. Alere Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 58. Becton Dickinson Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 59. BioMerieux Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 60. Roche Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 61. GE Healthcare Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 62. Hologic Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 63. Philips Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 64. PerkinElmer Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 65. Quest Diagnostics Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Breast Cancer Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Screening Tests
Table 3. Key Players of Diagnostic Tests
Table 4. Key Players of Monitoring Tests
Table 5. Global Breast Cancer Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Breast Cancer Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Breast Cancer Testing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Breast Cancer Testing Market Share by Region (2019-2024)
Table 9. Global Breast Cancer Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Breast Cancer Testing Market Share by Region (2025-2030)
Table 11. Breast Cancer Testing Market Trends
Table 12. Breast Cancer Testing Market Drivers
Table 13. Breast Cancer Testing Market Challenges
Table 14. Breast Cancer Testing Market Restraints
Table 15. Global Breast Cancer Testing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Breast Cancer Testing Revenue Share by Players (2019-2024)
Table 17. Global Top Breast Cancer Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Testing as of 2023)
Table 18. Global Breast Cancer Testing Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Breast Cancer Testing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Breast Cancer Testing, Headquarters and Area Served
Table 21. Global Key Players of Breast Cancer Testing, Product and Application
Table 22. Global Key Players of Breast Cancer Testing, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Breast Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Breast Cancer Testing Revenue Market Share by Type (2019-2024)
Table 26. Global Breast Cancer Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Breast Cancer Testing Revenue Market Share by Type (2025-2030)
Table 28. Global Breast Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Breast Cancer Testing Revenue Share by Application (2019-2024)
Table 30. Global Breast Cancer Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Breast Cancer Testing Revenue Share by Application (2025-2030)
Table 32. North America Breast Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Breast Cancer Testing Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Breast Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Breast Cancer Testing Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Breast Cancer Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Breast Cancer Testing Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Breast Cancer Testing Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Breast Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Breast Cancer Testing Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Breast Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Breast Cancer Testing Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Breast Cancer Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Breast Cancer Testing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Breast Cancer Testing Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Breast Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Breast Cancer Testing Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Breast Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Breast Cancer Testing Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Breast Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Breast Cancer Testing Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Breast Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Breast Cancer Testing Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Breast Cancer Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Breast Cancer Testing Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Breast Cancer Testing Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Breast Cancer Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Breast Cancer Testing Market Size by Country (2025-2030) & (US$ Million)
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott Breast Cancer Testing Product
Table 67. Abbott Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 68. Abbott Recent Developments
Table 69. Alere Company Details
Table 70. Alere Business Overview
Table 71. Alere Breast Cancer Testing Product
Table 72. Alere Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 73. Alere Recent Developments
Table 74. Becton Dickinson Company Details
Table 75. Becton Dickinson Business Overview
Table 76. Becton Dickinson Breast Cancer Testing Product
Table 77. Becton Dickinson Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 78. Becton Dickinson Recent Developments
Table 79. BioMerieux Company Details
Table 80. BioMerieux Business Overview
Table 81. BioMerieux Breast Cancer Testing Product
Table 82. BioMerieux Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 83. BioMerieux Recent Developments
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Breast Cancer Testing Product
Table 87. Roche Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 88. Roche Recent Developments
Table 89. GE Healthcare Company Details
Table 90. GE Healthcare Business Overview
Table 91. GE Healthcare Breast Cancer Testing Product
Table 92. GE Healthcare Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 93. GE Healthcare Recent Developments
Table 94. Hologic Company Details
Table 95. Hologic Business Overview
Table 96. Hologic Breast Cancer Testing Product
Table 97. Hologic Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 98. Hologic Recent Developments
Table 99. Philips Company Details
Table 100. Philips Business Overview
Table 101. Philips Breast Cancer Testing Product
Table 102. Philips Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 103. Philips Recent Developments
Table 104. PerkinElmer Company Details
Table 105. PerkinElmer Business Overview
Table 106. PerkinElmer Breast Cancer Testing Product
Table 107. PerkinElmer Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 108. PerkinElmer Recent Developments
Table 109. Quest Diagnostics Company Details
Table 110. Quest Diagnostics Business Overview
Table 111. Quest Diagnostics Breast Cancer Testing Product
Table 112. Quest Diagnostics Revenue in Breast Cancer Testing Business (2019-2024) & (US$ Million)
Table 113. Quest Diagnostics Recent Developments
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Breast Cancer Testing Market Share by Type: 2023 VS 2030
Figure 3. Screening Tests Features
Figure 4. Diagnostic Tests Features
Figure 5. Monitoring Tests Features
Figure 6. Global Breast Cancer Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Breast Cancer Testing Market Share by Application: 2023 VS 2030
Figure 8. Non-invasive Breast Cancer Case Studies
Figure 9. Invasive Breast Cancer Case Studies
Figure 10. Breast Cancer Testing Report Years Considered
Figure 11. Global Breast Cancer Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Breast Cancer Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Breast Cancer Testing Market Share by Region: 2023 VS 2030
Figure 14. Global Breast Cancer Testing Market Share by Players in 2023
Figure 15. Global Top Breast Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Testing as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Breast Cancer Testing Revenue in 2023
Figure 17. North America Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Breast Cancer Testing Market Share by Type (2019-2030)
Figure 19. North America Breast Cancer Testing Market Share by Application (2019-2030)
Figure 20. North America Breast Cancer Testing Market Share by Country (2019-2030)
Figure 21. United States Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Breast Cancer Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 24. Europe Breast Cancer Testing Market Share by Type (2019-2030)
Figure 25. Europe Breast Cancer Testing Market Share by Application (2019-2030)
Figure 26. Europe Breast Cancer Testing Market Share by Country (2019-2030)
Figure 27. Germany Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. China Breast Cancer Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 34. China Breast Cancer Testing Market Share by Type (2019-2030)
Figure 35. China Breast Cancer Testing Market Share by Application (2019-2030)
Figure 36. Asia Breast Cancer Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 37. Asia Breast Cancer Testing Market Share by Type (2019-2030)
Figure 38. Asia Breast Cancer Testing Market Share by Application (2019-2030)
Figure 39. Asia Breast Cancer Testing Market Share by Region (2019-2030)
Figure 40. Japan Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Taiwan Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Breast Cancer Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Breast Cancer Testing Market Share by Type (2019-2030)
Figure 48. Middle East, Africa, and Latin America Breast Cancer Testing Market Share by Application (2019-2030)
Figure 49. Middle East, Africa, and Latin America Breast Cancer Testing Market Share by Country (2019-2030)
Figure 50. Brazil Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Mexico Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Turkey Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Israel Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. GCC Countries Breast Cancer Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Abbott Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 57. Alere Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 58. Becton Dickinson Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 59. BioMerieux Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 60. Roche Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 61. GE Healthcare Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 62. Hologic Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 63. Philips Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 64. PerkinElmer Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 65. Quest Diagnostics Revenue Growth Rate in Breast Cancer Testing Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Circuit Simulator Market Research Report 2025
Mar 11, 25
Global Schematic Editor Market Research Report 2025
Mar 11, 25
Global Milk Green Tea Market Research Report 2025
Mar 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232